[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT9048260A0 - Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. - Google Patents

Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.

Info

Publication number
IT9048260A0
IT9048260A0 IT9048260A IT4826090A IT9048260A0 IT 9048260 A0 IT9048260 A0 IT 9048260A0 IT 9048260 A IT9048260 A IT 9048260A IT 4826090 A IT4826090 A IT 4826090A IT 9048260 A0 IT9048260 A0 IT 9048260A0
Authority
IT
Italy
Prior art keywords
treatment
application
pharmaceutical composition
respiratory disorders
respiratory
Prior art date
Application number
IT9048260A
Other languages
English (en)
Other versions
IT9048260A1 (it
IT1241996B (it
Inventor
James Barry Douglas Palmer
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27264677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT9048260(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898920392A external-priority patent/GB8920392D0/en
Priority claimed from GB898923644A external-priority patent/GB8923644D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT9048260A0 publication Critical patent/IT9048260A0/it
Publication of IT9048260A1 publication Critical patent/IT9048260A1/it
Application granted granted Critical
Publication of IT1241996B publication Critical patent/IT1241996B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IT48260A 1989-09-08 1990-09-07 Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. IT1241996B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898920392A GB8920392D0 (en) 1989-09-08 1989-09-08 Medicaments
GB898923644A GB8923644D0 (en) 1989-10-20 1989-10-20 Medicaments
SG166294A SG166294G (en) 1989-09-08 1994-11-18 Inhalation medicaments for treating respiratory disorders

Publications (3)

Publication Number Publication Date
IT9048260A0 true IT9048260A0 (it) 1990-09-07
IT9048260A1 IT9048260A1 (it) 1992-03-07
IT1241996B IT1241996B (it) 1994-02-02

Family

ID=27264677

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48260A IT1241996B (it) 1989-09-08 1990-09-07 Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.

Country Status (20)

Country Link
EP (1) EP0416951B1 (it)
JP (1) JP3042867B2 (it)
AT (1) ATE99941T1 (it)
BE (1) BE1003053A3 (it)
CA (1) CA2024916C (it)
CH (1) CH680983C9 (it)
DE (2) DE69005951T2 (it)
DK (1) DK0416951T3 (it)
ES (1) ES2062392T3 (it)
FR (1) FR2651677B1 (it)
HK (1) HK18695A (it)
HU (1) HU211272A9 (it)
IE (1) IE65535B1 (it)
IL (1) IL95590A (it)
IT (1) IT1241996B (it)
LU (1) LU90392I2 (it)
NL (1) NL990012I2 (it)
NZ (1) NZ235221A (it)
PH (1) PH27594A (it)
SG (1) SG166294G (it)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
HU0004452D0 (it) * 1991-12-18 2001-01-29 Astra Ab
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6645466B1 (en) 1998-11-13 2003-11-11 Jago Research Ag Dry powder for inhalation
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
DE60031504T2 (de) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
CN1294142C (zh) 2000-08-05 2007-01-10 葛兰素集团有限公司 作为抗炎剂的17β－硫代羧酸酯17α－芳基羰氧基雄甾烷衍生物
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
US7144908B2 (en) 2001-03-08 2006-12-05 Glaxo Group Limited Agonists of beta-adrenoceptors
WO2002076933A1 (en) 2001-03-22 2002-10-03 Glaxo Group Limited Formailide derivatives as beta2-adrenoreceptor agonists
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
ATE411334T1 (de) 2001-04-30 2008-10-15 Glaxo Group Ltd Antiphlogistische 7.beta.-carbothioate esterderivate von androstan mit einer 17.alpha.- zyklischen estergruppe
HU228508B1 (en) 2001-09-14 2013-03-28 Glaxo Group Ltd Phenethanolamine derivatives and pharmaceutical composition containing them
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
ATE396716T1 (de) † 2002-02-04 2008-06-15 Glaxo Group Ltd Zubereitung zur inhalation enthaltend ein glucocorticoid und einen beta 2-adrenorezeptor agonisten
EP1757281A3 (en) * 2002-02-04 2009-07-15 Glaxo Group Limited Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
JP2005519110A (ja) * 2002-03-04 2005-06-30 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規なケイ皮酸塩、その調製方法及び医薬品としての使用
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
CA2508692C (en) 2002-12-12 2012-04-03 Altana Pharma Ag Combination medicament
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
DK1658063T3 (da) 2003-08-06 2014-05-12 Galephar M F Fordelagtige kombinationer til inhalering af nacystelyn og bronkodilatorer
AP2006003734A0 (en) * 2004-03-12 2006-10-31 Cipla Ltd Inhalation formulation
MX2007000592A (es) 2004-07-16 2008-03-04 Almirall Lab Inhalador para la administracion de farmaceuticos en polvo, y un sistema de cartuchos de polvo para uso con este inhalador.
EP2063940B1 (en) 2006-12-22 2012-01-11 Almirall, S.A. Inhalation device for drugs in powder form
CN101744792B (zh) * 2008-12-17 2013-04-17 张凯 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺
PL3106149T3 (pl) 2009-05-29 2020-06-01 Pearl Therapeutics, Inc. Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
EP2991625A1 (en) * 2013-04-29 2016-03-09 Sanofi SA Inhalable pharmaceutical compositions and the inhaler devices containing them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
FR2588474B1 (fr) * 1985-10-16 1987-11-27 Cird Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste

Also Published As

Publication number Publication date
IL95590A (en) 1996-06-18
FR2651677B1 (fr) 1993-08-06
NL990012I2 (nl) 1999-09-01
EP0416951B1 (en) 1994-01-12
DE69005951T2 (de) 1994-05-26
NZ235221A (en) 1992-11-25
PH27594A (en) 1993-08-31
LU90392I2 (fr) 1999-06-28
CA2024916A1 (en) 1991-03-09
FR2651677A1 (fr) 1991-03-15
ES2062392T3 (es) 1994-12-16
IL95590A0 (en) 1991-09-16
IT9048260A1 (it) 1992-03-07
CH680983A5 (it) 1992-12-31
CH680983C1 (it) 2008-06-25
DK0416951T3 (da) 1994-02-14
IT1241996B (it) 1994-02-02
EP0416951A1 (en) 1991-03-13
BE1003053A3 (fr) 1991-11-05
IE903256A1 (en) 1991-03-13
JPH03167120A (ja) 1991-07-19
CA2024916C (en) 2002-07-09
DE69005951D1 (de) 1994-02-24
SG166294G (en) 1995-06-16
DE19975040I2 (de) 2006-07-13
IE65535B1 (en) 1995-11-01
HU211272A9 (en) 1995-11-28
ATE99941T1 (de) 1994-01-15
NL990012I1 (nl) 1999-07-01
HK18695A (en) 1995-02-17
JP3042867B2 (ja) 2000-05-22
CH680983C9 (it) 2008-08-15

Similar Documents

Publication Publication Date Title
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
IT8622482A0 (it) Spray di diidropiridina, procedimento per la sua produzione e suo impiego farmaceutico.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
NL193218B (nl) Werkwijze voor de bereiding van roestvrij staal.
IT1247784B (it) Composizione e metodo per la riduzione dell'appetito
IT1240302B (it) Struttura di scocca,procedimento ed apparecchio per la sua produzione.
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
IT8920917A0 (it) Processo per la preparazione di peraloeteri da peraloolefine e nuovi peraloeteri ottenuti.
FR2666334B1 (fr) Procede continu de preparation d'acrylamides et de methacrylamides n-substitues.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
ITRM940322A0 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
IT8920839A0 (it) Procedimento e dispositivo per la realizzazione di pannelli.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
IT8248390A0 (it) N-[4-(3-amminopropil)amminobutil]2,2-diidrossiotanammide come immuno -stimolante ed intermedio per laproduzione di sostanze carcinostati che, e procedimento per la sua preparazione
IT1231944B (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT8720352A0 (it) Sostanza profilattica e terapeutica per disturbi epatici.
EP0692965A4 (en) Method and composition for treatment of osteoporosis
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970910

MED Supplementary protection certificate for pharmaceutical products: no action taken

Free format text: CCP 683, 19991103; GLAXO GROUP LIMITED